Clinical Trials Directory

Trials / Completed

CompletedNCT02682199

Prospective Evaluation of Patient Reported Xerostomia After Whole Brain Radiation

Prospective Evaluation of Patient-Reported Xerostomia After Whole Brain Radiation

Status
Completed
Phase
Study type
Observational
Enrollment
100 (actual)
Sponsor
UNC Lineberger Comprehensive Cancer Center · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The goal of this prospective observational study is to investigate whether whole brain radiation leads to measurable xerostomia from parotid gland toxicity.

Detailed description

The parotids have not been traditionally considered an organ at risk / avoidance structure in whole brain radiation. However, patients receiving whole brain radiation sometimes complain of dry mouth. Investigators hypothesize that standard whole brain radiation fields cause an acute measurable increase in xerostomia at one month post-radiation, and that the severity of xerostomia is related to the dose received by the parotids. In this study, investigators will use the validated University of Michigan Xerostomia Questionnaire to prospectively collect baseline and post-radiation xerostomia scores up to 6 months after treatment. The radiation dose to the parotids will be evaluated to assess whether there is a dose-toxicity relationship. Investigators anticipate a total accrual of 60 patients with a goal of 48 evaluable patients.

Conditions

Timeline

Start date
2015-10-01
Primary completion
2018-05-01
Completion
2018-08-30
First posted
2016-02-15
Last updated
2019-09-23

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT02682199. Inclusion in this directory is not an endorsement.